EUVIMEDEUVIMED entdecken
Crossref

Treatment Timing May Challenge the Apparent Benefit of Intrathecal Therapy in Tuberculous Meningitis

Ercan Yılmaz iD, Nezihe Koker Özer iD, Erdem Topal iD

Clinical Infectious Diseases · 07.10.2026

DOI: 10.1093/cid/ciag635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 07.10.2026. Verfasst von Ercan Yılmaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Inonu University, Faculty of Medicine, Pediatric Allergy and Immunology Department, Malatya, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Intrathecal therapytreatment timingtuberculous meningitis

Autor:innen und Institutionen

  • Inonu University, Faculty of Medicine, Pediatric Allergy and Immunology Department, Malatya, Turkey.

ORCID-Profile: Ercan Yılmaz, Nezihe Koker Özer, Erdem Topal

Zitieren

APA

Yılmaz, E., Koker Özer, N., & Topal, E. (2026). Treatment Timing May Challenge the Apparent Benefit of Intrathecal Therapy in Tuberculous Meningitis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag635

Vancouver

Yılmaz E, Koker Özer N, Topal E. Treatment Timing May Challenge the Apparent Benefit of Intrathecal Therapy in Tuberculous Meningitis. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag635

BibTeX
@article{Ylmaz2026,
  author = {Yılmaz, Ercan and Koker Özer, Nezihe and Topal, Erdem},
  title = {Treatment Timing May Challenge the Apparent Benefit of Intrathecal Therapy in Tuberculous Meningitis},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag635}
}
Kostenlos starten →